Insulet Corporation
PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distribā¦ read more
Healthcare
Medical Devices
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$318.00
Price-1.73%
-$5.58
1Y
Price
Market Cap
$22.385b
Large
Price/Earnings 3y Avg5y Avg
97.3x
Premium
Premium
Financials Overview
Key metrics over the past few years+10.8%
EBITDA Margin+3.5%
Net Profit Margin+26.7%
Free Cash Flow MarginRevenue
$2.360b
+13.9%
1y CAGR+22.0%
3y CAGR+21.2%
5y CAGREarnings
$236.100m
-43.6%
1y CAGR+1481.3%
3y CAGR+1092.8%
5y CAGREPS
$3.29
-43.1%
1y CAGR+1384.5%
3y CAGR+1020.4%
5y CAGRBook Value
$1.463b
$3.469b
Assets$2.006b
Liabilities$1.417b
DebtDebt to Assets
40.9%
3.5x
Debt to EBITDAFree Cash Flow
$392.600m
+28.6%
1y CAGR+215.8%
3y CAGR+181.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company